255
staff
Maxwell DeGregorio
Maxwell DeGregorio is an Associate at the Center for Financial Markets at the Milken Institute.
staff
Nicole Valentine
Nicole Valentine is the director, FinTech at the Milken Institute with over a decade of fina
ncial services, international mergers and acquisitions, technology, and innovation experience.
+ Read More
staff
Arnav Kumar
Arnav Kumar is an intern in the FinTech program within the Center for Financial Markets. Kumar wo
rks on FinTech subsector analysis research to support policy efforts and new thought leadership at the Institute.
+ Read More
report
Analysis of the FinTech Policy Landscape
The Milken Institute FinTech Program is tracking the ongoing development of FinTech-related legisla
tion introduced in the 117th Congress.
+ Read More
report
Share the Data: Overcoming Trade-Offs in Tech Regulation
DOWNLOAD SUM
report
Comment Letter to the Global Financial Innovation Network
The Global Financial Innovation Network (GFIN), composed of 11 regulatory authorities from around t
he world, is seeking to formally launch an effort that would potentially lead to greater regulatory collaboration through information sharing efforts, tes
+ Read More
report
Spare Tire? Stock Markets and Systemic Banking Crises
Do stock markets act as a “spare tire” during banking crises by providing an alternative form of co
rporate financing when the banking system goes flat?
+ Read More
report
Framing the Issues: De-Risking and Its Consequences for Global Commerce and the Financial System
On March 4, 2015, the Milken Institute Center for Financial Markets hosted a day-long roundtable,&n
bsp;Framing the Issues: De-Risking and Its Consequences for Global Commerce and the Financial System, with AML/CFT policymakers, regulators, fina
+ Read More
report
Disruptive Technology and Securities Regulation
Abstract
report
Hedging Pipeline Risk in Pharma: FDA Swaps and Annuities
The cost of capital to conduct medical R&D is high because investors must be compensated with s
ignificant returns to offset the risky and long drug-development process.
+ Read More
report
Comment Letter: Policy on No-Action Letters and the CFPB Product Sandbox
In this letter, we provide initial reactions and thoughts with regards to both the proposed policy
on No-Action Letters (NALs) and the Product Sandbox proposal, and propose several recommendations to further strengthen the proposal.
+ Read More
report
Comment Letter to the OCC: Special Purpose National Bank Charters for FinTech Companies
The Milken Institute Center for Financial Markets provided a response to the Office of th
e Comptroller of the Currency (OCC) upon request for comments regarding
+ Read More